开放期刊系统

肝细胞癌微创治疗的技术进展与多学科综合策略

刘 星宇, 张 松男

摘要

肝细胞癌(HCC)是全球范围内常见的恶性肿瘤之一,其发病率和死亡率居高不下。随着医疗技术的不断发展,微创治疗在HCC治疗中发挥着越来越重要的作用。本文综述了近年来HCC微创治疗的技术进展,包括经皮消融技术、经动脉介入治疗以及局部与系统治疗的联合策略,并探讨了多学科协作在HCC治疗中的关键作用。通过分析最新临床研究成果和技术创新,本文旨在为HCC的个体化治疗提供参考依据。

关键词

肝细胞癌;恶性肿瘤;微创治疗

全文:

PDF

参考

[1]Liu Y,Li S,Wan X,et al. Efficacy and safety of thermal ablation in patients with liver metastases:a systematic review and

meta-analysis. Int J Hyperthermia. 2022;39(1):1317-1329. doi:10.1080/02656736.2022.2112309

[2]Perlberger G,Van Cutsem E,Verslype C,et al. Ultrasound guidance versus CT guidance with stereotactic navigation in thermal

ablation for hepatocellular carcinoma:a comparative retrospective analysis. Eur J Surg Oncol. 2025;51(3):e45-e52. doi:

10.1016/j.ejso.2024.12.001

[3]Huang Y,Wang Y,Yang L,et al. Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma ≤5 cm:a

propensity score analysis. Eur Radiol. 2023;33(2):1023-1032. doi:10.1007/s00330-022-09053-2

[4]Dong J,Li Z,Chen Y,et al. Yttrium-90 radioembolization versus conventional transarterial chemoembolization for unresectable

hepatocellular carcinoma:a multicenter retrospective study. J Hepatol. 2024;80(4):e123-e134. doi:10.1016/j.jhep.2023.11.015

[5]Zhang L,Liu X,Zhang X,et al. Camrelizumab plus apatinib combined with TACE for unresectable hepatocellular carcinoma:a

multicenter,phase II trial(CARES-005). J Clin Oncol. 2024;42(15_suppl):4082. doi:10.1200/JCO.2024.42.15_suppl.4082

[6]Zhou J,Sun H,Wang Z,et al. Lenvatinib plus TACE for advanced hepatocellular carcinoma:final results of the LAUNCH trial.

Hepatology. 2025;81(2):567-579. doi:10.1097/HEP.0000000000000456

[7]Cao M,Li W,Zhang H,et al. Selective internal radiation therapy with yttrium-90 for large unresectable hepatocellular carcinoma:

a real-world Chinese experience. Liver Cancer. 2025;14(1):45-58. doi:10.1159/000533921

[8]Chen X,Feng S,Liu Y,et al. Artificial intelligence-based multimodal fusion system for predicting immunotherapy response in

hepatocellular carcinoma. npj Precis Oncol. 2025;9:12. doi:10.1038/s41698-025-00305-8


(0 摘要 Views, 0 PDF Downloads)

Refbacks

  • 当前没有refback。